Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Checkpoint Therapeutics, Inc. - Common Stock (NQ:CKPT)

4.260 UNCHANGED
Last Price Updated: 4:00 PM EDT, May 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Checkpoint Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 Next >
On Friday, there are stocks with unusual volume. Let's take a look.
Let's have a look at what is happening on the US markets on Friday. Below you can find the stocks with an unusual volume in today's session. 
Via Chartmill
Unusual volume stocks are being observed in Wednesday's session.
Which stocks have an unusual volume on Wednesday? 
Via Chartmill
Unusual volume stocks are being observed in Tuesday's session.
In today's session, these stocks are experiencing unusual volume. 
Via Chartmill
This Lennar Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
 
Via Benzinga
Keep an eye on the top gainers and losers in Monday's session.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
Monday's session: top gainers and losers
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
Dow Tumbles Over 600 Points; Mineralys Therapeutics Shares Spike Higher
 
Via Benzinga
Topics Stocks
Let's uncover which stocks are experiencing notable gaps during today's session.
The session on Monday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session. 
Via Chartmill
India-Based Sun Pharma To Buy US Cancer Firm Checkpoint Therapeutics: Details
Sun Pharma to acquire Checkpoint Therapeutics for $4.10 per share, with potential CVR. FDA approves Unloxcyt, the first PD-L1 blocker for advanced cSCC. 
Via Benzinga
Nasdaq Dips Over 3%; Checkpoint Therapeutics Shares Jump
 
Via Benzinga
Top movers in Monday's pre-market session
The US market is yet to commence its session on Monday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
Via Chartmill
US Stocks Likely To Open Lower After Trump Hints At Looming Recession: Expert Says Can't Rule Out A Bear Market As Indices Inch Towards Correction Territory
U.S. stock futures declined on Monday after a small bout of relief on Friday as indices neared the correction zone. 
Via Benzinga
Topics Government
Why Checkpoint Therapeutics Shares Are Trading Higher By Around 66%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
This PG&E Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
 
Via Benzinga
FDA Approves Checkpoint Therapeutics' Skin Cancer Drug One Year After Rejection
Checkpoint Therapeutics' Unloxcyt wins FDA approval for advanced cSCC, marking the company's entry into the U.S. market, valued over $1 billion annually. 
Via Benzinga
US Stocks To Open Higher Ahead Of Fed's Decision This Week: Analyst Says 'Santa Comes Later In December'
U.S. stock futures were trading higher after the Nasdaq 100 extended its relentless climb last week, nearing the 22,000-point milestone. 
Via Benzinga
Topics Economy
CKPT Stock Earnings: Checkpoint Therapeutics Beats EPS, Beats Revenue for Q2 2024
CKPT stock results show that Checkpoint Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
CKPT Stock Earnings: Checkpoint Therapeutics Misses EPS for Q1 2024
CKPT stock results show that Checkpoint Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
CKPT Stock Earnings: Checkpoint Therapeutics Misses EPS, Misses Revenue for Q4 2023
CKPT stock results show that Checkpoint Therapeutics missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Pinterest, Checkpoint Therapeutics And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed higher by around 300 points on Friday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Nasdaq Gains 100 Points; Biomerica Shares Spike Higher
U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite gaining over 100 points on Monday. The Dow traded up 0.01% to 37,307.40 while the NASDAQ rose 0.71% to 14,919.07.... 
Via Benzinga
Topics Stocks
Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
Crude Oil Rises 3%; US Housing Market Index Increases In December
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 50 points on Monday. The Dow traded up 0.14% to 37,356.29 while the NASDAQ rose 0.25% to 14,851.19. The S&P 500... 
Via Benzinga
Topics Stocks
Dow Gains Over 50 Points; Nippon Steel To Acquire U. S. Steel
U.S. stocks traded higher this morning, with the Dow Jones index gaining around 50 points on Monday. Following the market opening Monday, the Dow traded up 0.15% to 37,362.28 while the NASDAQ rose... 
Via Benzinga
Topics Stocks
What's Going On With Checkpoint Therapeutics (CKPT) Stock Nosediving?
Checkpoint Therapeutics Inc (NASDAQ: CKPT) shares are trading lower by 52.7% to $1.57 Monday morning after the company received a complete response letter (CRL) from the FDA regarding their application... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.